These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9931100)

  • 21. Oestrogens and the heart.
    Rosano GM; Panina G
    Therapie; 1999; 54(3):381-5. PubMed ID: 10500455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone replacement therapy and inflammation: interactions in cardiovascular disease.
    Miller AP; Chen YF; Xing D; Feng W; Oparil S
    Hypertension; 2003 Oct; 42(4):657-63. PubMed ID: 12913055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
    Hulley S; Grady D; Bush T; Furberg C; Herrington D; Riggs B; Vittinghoff E
    JAMA; 1998 Aug; 280(7):605-13. PubMed ID: 9718051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection.
    Mijatovic V; van der Mooren MJ; Stehouwer CD; Netelenbos JC; Kenemans P
    Gynecol Endocrinol; 1999 Apr; 13(2):130-44. PubMed ID: 10399059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of hormone replacement therapy in matrix metalloproteinase expression and intimal hyperplasia development after vascular injury.
    Mountain DJ; Freeman MB; Kirkpatrick SS; Cook RB; Chalk JE; Stevens SL; Goldman MH; Grandas OH
    Ann Vasc Surg; 2013 Apr; 27(3):337-45. PubMed ID: 23088810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sex hormone replacement following menopause--for all women? A plea for prevention using estrogens and gestagens].
    Nocke W
    Ther Umsch; 1995 Oct; 52(10):693-704. PubMed ID: 7482382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KEEPS: The Kronos Early Estrogen Prevention Study.
    Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
    Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.
    Simon JA; Hunninghake DB; Agarwal SK; Lin F; Cauley JA; Ireland CC; Pickar JH
    Ann Intern Med; 2001 Oct; 135(7):493-501. PubMed ID: 11578152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of estrogen and estrogen-related drugs in cardiovascular diseases.
    Ogita H; Node K; Kitakaze M
    Curr Drug Metab; 2003 Dec; 4(6):497-504. PubMed ID: 14683477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congress on women's health Trudy Bush lecture 2014: new insights into sex Hormones and Cardiovascular disease.
    Miller VM
    J Womens Health (Larchmt); 2014 Dec; 23(12):997-1004. PubMed ID: 25495365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention of cardiovascular risk in menopause women: role of ovarian hormones].
    Rosano GM; Leonardo F; Ricci S; Serra GB; Chierchia SL
    Ann Ist Super Sanita; 1997; 33(2):199-202. PubMed ID: 9470240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of cardiac hypertrophy by estrogens.
    Pelzer T; Shamim A; Wölfges S; Schumann M; Neyses L
    Adv Exp Med Biol; 1997; 432():83-9. PubMed ID: 9433514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postmenopausal hormone replacement therapy and the vascular wall: epidemiology and clinical studies.
    Joswig M; Hach-Wunderle V; von Holst T; Nawroth PP
    Vasa; 2000 Nov; 29(4):243-51. PubMed ID: 11141646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormone replacement therapy and cardioprotection: the end of the tale?
    Rosano GM; Vitale C; Silvestri A; Fini M
    Ann N Y Acad Sci; 2003 Nov; 997():351-7. PubMed ID: 14644842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular disease in women and noncontraceptive use of hormones: a feminist analysis.
    MacPherson KI
    ANS Adv Nurs Sci; 1992 Jun; 14(4):34-49. PubMed ID: 1605587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex hormones, lipoproteins, and cardiovascular risk.
    Seed M
    Atherosclerosis; 1991 Sep; 90(1):1-7. PubMed ID: 1799395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender differences in the cardiovascular effect of sex hormones.
    Vitale C; Mendelsohn ME; Rosano GM
    Nat Rev Cardiol; 2009 Aug; 6(8):532-42. PubMed ID: 19564884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preserving cardiovascular benefits of hormone replacement therapy.
    Bush TL
    J Reprod Med; 2000 Mar; 45(3 Suppl):259-73. PubMed ID: 10756507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.
    Grodstein F; Manson JE; Colditz GA; Willett WC; Speizer FE; Stampfer MJ
    Ann Intern Med; 2000 Dec; 133(12):933-41. PubMed ID: 11119394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular pharmacology of hormone replacement therapy.
    Rosano GM; Panina G
    Drugs Aging; 1999 Sep; 15(3):219-34. PubMed ID: 10503814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.